Ocular Histoplasmosis: Symptoms, Causes, and Treatments
Updated: Nov 11
Medically reviewed by Dr. Baraa Alnahhal, MD · Last reviewed: October 2026
Quick Answer
Presumed ocular histoplasmosis syndrome (POHS) is a rare retinal condition caused by exposure to the Histoplasma capsulatum fungus, found in soil contaminated by bird or bat droppings. It causes retinal scarring and abnormal blood vessel growth that can cause permanent central vision loss if untreated. Injections or laser treatment stop vessel growth, and early treatment is critical.
What the research says
Choroidal neovascularization is the main threat to vision. In a Minnesota population study of 87 people with presumed ocular histoplasmosis, abnormal blood vessel growth occurred in 17.4% of affected eyes, and 16.8% had reduced vision (worse than 20/40) at last follow-up (Xu et al., Ocul Immunol Inflamm, 2022) [3].
Anti-VEGF injections improved vision. In a small prospective study of 21 patients, as-needed ranibizumab improved vision by about 2 lines and reduced retinal thickness by about 100 μm at 12 months, with no adverse events (Wood et al., Ophthalmic Surg Lasers Imaging Retina, 2018) [4].
What is ocular histoplasmosis (POHS)?
Presumed Ocular Histoplasmosis Syndrome (POHS) is a rare but serious eye condition that develops as a complication of exposure to the Histoplasma capsulatum fungus. This fungus, which typically causes a lung infection known as histoplasmosis, can eventually lead to changes and scarring in the retinas. POHS is characterized by the formation of abnormal blood vessels in the retina, a process called choroidal neovascularization, which can cause permanent damage and vision loss if not addressed promptly.
The condition is considered "presumed" because it often appears decades after the initial fungal exposure, and there is typically no active fungal infection in the eye at the time of diagnosis. Instead, POHS is the result of long-term changes triggered by the body's previous encounter with the fungus. Because early stages are often asymptomatic, regular eye examinations are vital for individuals with known risk factors.

What are the symptoms of ocular histoplasmosis?
In its early stages, Ocular Histoplasmosis typically does not cause noticeable symptoms. Patients often remain unaware of the condition until choroidal neovascularization begins to affect their vision. Once this occurs, the symptoms can range from mild blurring to significant central vision distortion.
Visual distortion: Straight lines appear wavy or crooked; objects appear different sizes in each eye.
Vision loss: Painless blurred vision or central blind spots (scotomas).
Perceptual changes: Colors appearing dull or faded; experiencing flashes or flickering (photopsia).
What causes ocular histoplasmosis, and how is it transmitted?
The primary cause of POHS is the inhalation of Histoplasma capsulatum spores. This fungus thrives in soil that contains high levels of bird or bat droppings, particularly from chickens. Activities such as plowing fields, digging, or construction can stir these spores into the air, allowing them to be breathed into the lungs. [1]
POHS happens when you're exposed to the fungus that causes histoplasmosis, which causes changes and scarring in your retinas... It's not from an active fungal infection in your eye.
It is important to note that POHS is not contagious and cannot be spread from person to person. [1] While the initial lung infection may be acute, the ocular complications can manifest many years later, even in individuals who did not experience severe respiratory symptoms during their initial exposure.
What are the risk factors for ocular histoplasmosis, and where is it common?
Geographic location is one of the most significant risk factors for POHS. The Histoplasma fungus is highly prevalent in the central United States, particularly within the Ohio and Mississippi River valleys. [1] Individuals living in or traveling to these regions face a higher likelihood of exposure.
Environmental: Living in the Ohio/Mississippi River valleys; spending time near bird or bat habitats.
Occupational: Farming, construction work, or handling poultry.
Personal history: Current or past tobacco use; having a weakened immune system.

How is ocular histoplasmosis diagnosed?
Diagnosing Ocular Histoplasmosis requires a comprehensive evaluation by an eye care specialist. The process typically begins with a dilated eye exam and a slit lamp examination to visualize the retina and identify any characteristic scarring or abnormal vessel growth.
Advanced imaging technologies are often employed to confirm the diagnosis and assess the extent of the damage. Fluorescein angiography uses a specialized dye to highlight blood flow in the retina, while Optical Coherence Tomography (OCT) provides high-resolution cross-sectional images of the retinal layers. Fundus autofluorescence may also be used to detect retinal changes without the need for injectable dyes.
How is ocular histoplasmosis managed and treated?
Treatment for Ocular Histoplasmosis is only necessary when symptoms begin to affect a patient's vision. The primary goal of management is to stop the growth of abnormal blood vessels and prevent further scarring.
Anti-VEGF therapy: This is the most common and effective treatment, involving injections of medication into the eye to block the signals that stimulate abnormal blood vessel growth.
Photodynamic therapy (PDT): A light-sensitive drug is injected into the arm and then activated in the eye using a low-power laser to destroy abnormal vessels.
Laser photocoagulation: A specially tuned laser is used to zap and destroy new blood vessels, typically reserved for cases where the vessels are not located in the center of the retina.
Antifungal medications, while useful for treating active lung infections, are not effective for treating the retinal changes associated with POHS.

Conclusion
Ocular Histoplasmosis is a complex condition that highlights the long-term impact of fungal exposure on vision. While the prospect of permanent vision loss is significant, early detection and modern treatments like anti-VEGF therapy offer a strong chance of vision preservation. Understanding the geographic risks and seeking immediate care for any visual changes are the most effective ways to manage this rare syndrome.
What should you do about ocular histoplasmosis now?
If you live in a high-risk geographic area or have a history of histoplasmosis, schedule a comprehensive dilated eye exam today. Early intervention is the key to protecting your central vision from the long-term effects of POHS.
Frequently Asked Questions
What exactly is POHS?
POHS is a rare eye condition caused by past exposure to the Histoplasma fungus, leading to retinal scarring and abnormal blood vessel growth.
Is Ocular Histoplasmosis contagious?
No, the condition is not contagious and cannot be spread between individuals.
Can I have POHS without knowing it?
Yes, early stages are often asymptomatic, and vision changes only occur once abnormal blood vessels begin to form.
How does the fungus get into the eye?
The fungus is inhaled into the lungs and later causes systemic changes that can lead to retinal scarring, though it is not an active eye infection.
What are the first signs of vision trouble?
Common early signs include blurred vision, central blind spots, or straight lines appearing wavy.
Who is at the highest risk for POHS?
People living in the Ohio and Mississippi River valleys, farmers, and those who handle birds or bats are at higher risk.
Does smoking affect POHS?
Yes, a history of smoking or current tobacco use is a recognized risk factor for developing the condition.
How is the condition diagnosed?
Diagnosis involves a dilated eye exam and advanced imaging like OCT or fluorescein angiography.
What is the best treatment for POHS?
Anti-VEGF injections are currently considered the most effective treatment for stopping abnormal vessel growth.
Are antifungal drugs used for POHS?
No, antifungals do not treat the retinal scarring or vessel growth in POHS, though they may be used for lung infections.
Can vision loss from POHS be reversed?
Early treatment can often stabilize or improve vision, but vision already lost may not fully return, and delayed treatment raises the risk of permanent damage.
Is the treatment painful?
Eye injections are performed with numbing agents to minimize discomfort, and most patients tolerate the procedure well.
Can POHS come back after treatment?
Yes, neovascularization can recur years later, requiring ongoing monitoring by an eye specialist.
What happens if I don't treat POHS?
Untreated POHS can lead to permanent central vision loss due to extensive retinal scarring.
What is low vision rehabilitation?
Low vision rehabilitation is a form of therapy that helps individuals with permanent vision loss use aids and modified techniques to maintain independence.
Helpful Resources
Medical Disclaimer
This content is for informational purposes only and does not constitute medical advice. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
Related Reading
Histoplasmosis: Symptoms, Causes & Treatment explains the fungal lung infection behind ocular histoplasmosis.
Amsler Grid Eye Test: How to Check Your Central Vision at Home explains the simple grid test used to spot central vision changes at home.
Retinal Imaging: Fundus Photos, OCT and Angiography Explained explains the eye scans used to find and track retina damage.
Understanding Retinal Hemorrhage: Causes, Types, and Vision Health explains bleeding in the retina, its causes and its effect on vision.
References
Mayo Clinic Staff. Histoplasmosis: Symptoms & causes. Mayo Clinic. May 16, 2025. https://www.mayoclinic.org/diseases-conditions/histoplasmosis/symptoms-causes/syc-20373495
Mayo Clinic Staff. Histoplasmosis: Diagnosis & treatment. Mayo Clinic. May 16, 2025. https://www.mayoclinic.org/diseases-conditions/histoplasmosis/diagnosis-treatment/drc-20373499
Xu TT, et al. Epidemiology and Clinical Characteristics of Presumed Ocular Histoplasmosis in Olmsted County, Minnesota. Ocul Immunol Inflamm. 2022;30(5):1039-1043. PMID 33661067. https://doi.org/10.1080/09273948.2020.1859549
Wood EH, et al. PRN Ranibizumab in the Treatment of Choroidal Neovascularization Secondary to Ocular Histoplasmosis. Ophthalmic Surg Lasers Imaging Retina. 2018;49(1):20-26. PMID 29304262. https://doi.org/10.3928/23258160-20171215-03




Comments